Behavioral counseling and abstinence‐contingent take‐home buprenorphine in general practitioners’ offices in Malaysia: a randomized, open‐label clinical trial-Reference-Cited by-同舟云学术

Behavioral counseling and abstinence‐contingent take‐home buprenorphine in general practitioners’ offices in Malaysia: a randomized, open‐label clinical trial

Published:2021-01-21 Issue:8 Volume:116 Page:2135-2149
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Schottenfeld Richard S.¹^ORCID,Chawarski Marek C.²^ORCID,Mazlan Mahmud³

Affiliation:

1. Department of Psychiatry and Behavioral Sciences Howard University College of Medicine Washington DC USA

2. Department of Psychiatry Yale School of Medicine New Haven CT USA

3. Kuala Lumpur Malaysia

Funder

National Institute on Drug Abuse

State of Connecticut Department of Mental Health and Addiction Services

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/add.15399

Reference44 articles.

1. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013

2. Substance abuse and the HIV situation in Malaysia

3. Buprenorphine/naloxone treatment practices in Malaysia: Results of national surveys of physicians and patients

4. Buprenorphine Treatment By Primary Care Providers, Psychiatrists, Addiction Specialists, And Others

5. Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of task-sharing interventions for substance use and substance use disorder in low- and middle-income countries;Drug and Alcohol Dependence;2024-03

2. Relative effectiveness of medications for opioid-related disorders: A systematic review and network meta-analysis of randomized controlled trials;PLOS ONE;2022-03-31

3. Behavioral counseling and abstinence‐contingent take‐home buprenorphine in general practitioners’ offices in Malaysia: a randomized, open‐label clinical trial;Addiction;2021-01-21